PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1518496
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1518496
Pharmaceutical Cartridges Market - By Component (Plungers, Vials [Glass, Plastic], Seals), Type (Dual Chamber, Large-volume), Capacity, Usage Device (Pen Injectors, Autoinjectors, Wearable Injectors), Application, End-user - Global Forecast 2024 - 2032
Pharmaceutical Cartridges Market size is projected to record 7.3% CAGR from 2024 to 2032, due to the rise in pharmaceutical production worldwide along with the strong need for actively supporting efficient drug delivery and packaging solutions. With the expanding pharmaceutical production, cartridges are used for ensuring accurate dosing and sterile packaging.
Engineers and manufacturers are focusing on advancements in materials and designs to meet the evolving needs of the pharmaceutical industry. This growth is enhancing reliability and efficiency in drug delivery systems for improved healthcare outcomes globally. For instance, in May 2022, SCHOTT announced a double-digit million Euro investment in ready-to-use cartridge production for marking a new era in pharmaceutical cartridges. This initiative helped in enhancing manufacturing capabilities and meeting the growing demand for advanced drug delivery solutions.
The overall market is segregated into component, type, usage device, capacity, application, end-user, and region.
In terms of component, the pharmaceutical cartridges market from the seals segment is expected to record significant CAGR from 2024 to 2032. Seals for pharmaceutical cartridges are used for ensuring the integrity and sterility of medications by preventing contamination and leakage. Manufacturers are developing advanced sealing technologies to enhance performance and reliability. Rising innovations in materials and designs are also ensuring compatibility with various drug formulations for maintaining the efficacy and safety of medications throughout their shelf life.
By application, the pharmaceutical cartridges industry from the cardiology segment is projected to rise from 2024 to 2032 owing to the strong need for providing precise and reliable drug delivery systems. These cartridges are enhancing the administration of medications for heart conditions whilst ensuring consistent dosages and reducing the risk of human errors. Researchers and medical professionals are also exploring new ways to integrate these cartridges into innovative treatment protocols to improve patient outcomes and streamline the management of cardiovascular diseases.
Regionally, the Asia Pacific pharmaceutical cartridges market size is projected to exhibit robust growth between 2024 and 2032, fueled by increasing expansion into emerging markets, driven by patient safety and convenience. Manufacturers are developing cartridges that ensure precise dosing and easy administration for enhancing overall patient care in the region. Subsequently, the growing need for improved cartridge designs and materials for supporting safer, more effective treatments whilst facilitating patient compliance and comfort with user-friendly features will drive the regional product demand.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360 degree synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising demand for easy-to-use and convenient pharmaceutical packaging solutions
- 3.2.1.2 Growing advances in pharmaceutical drug delivery and manufacturing technology
- 3.2.1.3 Increasing focus on biologics and the trend towards personalized medicine
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Manufacturing complexity
- 3.2.2.2 Stringent regulatory framework
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Million)
- 5.1 Key trends
- 5.2 Plungers
- 5.2.1 Chlorinated butyl rubber
- 5.2.2 Bromobutyl rubber
- 5.3 Vials
- 5.3.1 Glass
- 5.3.1.1 Type 1
- 5.3.1.2 Type 2
- 5.3.1.3 Type 3
- 5.3.2 Plastic
- 5.3.2.1 Polypropylene (PP)
- 5.3.2.2 Cyclic olefin copolymer (COC)
- 5.3.2.3 Cyclic olefin polymer (COP)
- 5.3.2.4 Polyethylene
- 5.3.2.5 Other plastic vials
- 5.3.1 Glass
- 5.4 Seals
Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Million)
- 6.1 Key trends
- 6.2 Dual chamber cartridges
- 6.3 Large-volume cartridges
Chapter 7 Market Estimates and Forecast, By Capacity, 2021 - 2032 ($ Million)
- 7.1 Key trends
- 7.2 0.5 ml
- 7.3 1.8 ml
- 7.4 2ml to 2.5 ml
- 7.5 3 ml
- 7.6 5 ml
- 7.7 More than 10 ml
Chapter 8 Market Estimates and Forecast, By Usage Device, 2021 - 2032 ($ Million)
- 8.1 Key trends
- 8.2 Pen injectors
- 8.3 Autoinjectors
- 8.4 Wearable injectors
- 8.5 Other usage devices
Chapter 9 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Million)
- 9.1 Key trends
- 9.2 Dental care
- 9.3 Diabetes care
- 9.4 Neurology
- 9.5 Cardiology
- 9.6 Oncology
- 9.7 Other applications
Chapter 10 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Million)
- 10.1 Key trends
- 10.2 Hospitals
- 10.3 Specialty clinics
- 10.4 Ambulatory surgical centers
- 10.5 Homecare settings
- 10.6 Other end-users
Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Million)
- 11.1 Key trends, by region
- 11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
- 11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 France
- 11.3.4 Spain
- 11.3.5 Italy
- 11.3.6 Rest of Europe
- 11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 Rest of Asia Pacific
- 11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Rest of Latin America
- 11.6 Middle East and Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
- 12.1 AptarGroup, Inc.
- 12.2 Baxter International Inc.
- 12.3 Dätwyler Holding Inc.
- 12.4 Gerresheimer AG
- 12.5 Merck KGaA
- 12.6 Nipro Corporation
- 12.7 Schott Group
- 12.8 Shandong Medicinal Glass Co., Ltd.
- 12.9 Stevanato Group
- 12.10 Transcoject GmbH
- 12.11 West Pharmaceutical Services, Inc.
- 12.12 Ypsomed AG
